Biomarkers in Substance Use Disorders
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The prevention and treatment of substance use disorders (SUDs), including addiction, would benefit from having better biomarkers for the classification of patients into categories that are reproducible and have predictive validity. Direct measurement of drugs or their metabolites in various body fluids constitutes a clinically valuable biomarker but one that can only be used to corroborate acute or relatively recent drug use. Thus, there is an urgent need for biomarkers that reflect chronic drug exposure as well as biomarkers that predict or correlate with disease trajectories and treatment responses. Advances in tools and technologies to investigate genetics, epigenetics and epitranscriptomics, and human brain function and neurochemistry (brain imaging tools including EEG) offer unprecedented opportunities for the development of such biomarkers. Progress in this area will not only enhance our ability to screen and treat patients with SUDs but also accelerate research on the neurobiological processes that underlie SUDs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationThe Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Self-citationAddiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
Self-citationNucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement
Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S. J., Theobald, D. E. H., Lääne, K., Peña, Y., Murphy, E. R., Shah, Y., Probst, K., et al. (2007) · Science · doi:10.1126/science.1137073 · Cited by 1,188
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Self-citationAddiction: Beyond dopamine reward circuitry
Volkow, N. D., Wang, G.-J., Fowler, J. S., Tomasi, D., & Telang, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010654108 · Cited by 959
Self-citationCell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward
Lobo, M. K., Covington, H. E., Chaudhury, D., Friedman, A. K., Sun, H., Damez-Werno, D., Dietz, D. M., Zaman, S., Koo, J. W., Kennedy, P. J., et al. (2010) · Science · doi:10.1126/science.1188472 · Cited by 880
Neural mechanisms of genetic risk for impulsivity and violence in humans
Meyer-Lindenberg, A., Buckholtz, J. W., Kolachana, B., R. Hariri, A., Pezawas, L., Blasi, G., Wabnitz, A., Honea, R., Verchinski, B., Callicott, J. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511311103 · Cited by 876
Edenberg, H. J. (2007) · Europe PMC (PubMed Central) · Cited by 767
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674
Research works printed but not linked: 1
- Edenberg H. J., 2007, Alcohol Res. Health, 30, 5
Cited by
Items 101–145 of 145
Lee, S. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.117690 · Cited by 5
Identification of Plasma Metabolites Responding to Oxycodone Exposure in Rats
Vu, T., Godbole, S. V., Carrette, L. L. G., Maturin, L., George, O., Saba, L. M., & Kechris, K. J. (2025) · Metabolites · doi:10.3390/metabo15020095 · Cited by 4
“For instance, by comparing metabolomics profiles across different addiction phases, including current drug abusers, withdrawal periods, durations of abstinence, relapse, or no drug use, biomarkers associated with the addiction trajectories can be identified [3,5].”
García‐Marchena, N., Marcos, A., Flores-López, M., Moreno, M. G., Requena-Ocaña, N., Porras-Perales, Ó., Torres-Galván, S., Araos, P. F., Serrano, A., Muga, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051137 · Cited by 4
“Consequently, relevant molecular signaling systems involved in the etiology and pathophysiology of addictive processes have been extensively explored to identify valid and reliable biomarkers [9].”
BackgroundBøhle, K., Otterholt, E., & Bjørkly, S. K. (2022) · Substance Abuse Research and Treatment · doi:10.1177/11782218221106797 · Cited by 4
“The aim of this study was to investigate whether there was (1) an association between salivary cortisol levels and dropping out from inpatient”
BackgroundMaerean, N., Kuo, S., Jones, M. B., Salas, R., Oh, H., Rossi, M., McCauley, S. R., & Lin, C.-Y. R. (2025) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000409 · Cited by 3
Copersino, M. L., Patel, R., Price, J. S., Visser, K. F., Vitaliano, G. D., Plitman, E., Lukas, S. E., Weiss, R. D., Janes, A. C., & Chakravarty, M. M. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107728 · Cited by 3
“The search for biomarkers of disease progression or chronicity of drug exposure that would benefit research efforts aimed at improving the diagnosis and treatment of SUD has been elusive (Volkow et al., 2015).”
BackgroundNeuromarkers in addiction: definitions, development strategies, and recent advances
Harp, N. R., Wager, T. D., & Kober, H. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02766-2 · Cited by 4
“Objective measures of engagement of biological (i.e., brain) targets and treatment response in SUD are sorely needed (Volkow et al. 2015).”
Peripheral Biomarkers Of Tobacco-Use Disorder: A Systematic Review
Newton, D. F. (2019) · Addiction & Addictive Disorders · doi:10.24966/aad-7276/100026 · Cited by 3
Implications of Impulsivity on Criminal Behavior in Individuals With Substance Use Disorder
Fantin, E. H., Bumaguin, D. B., Ornell, F. R., Ruwel, A. G., DIEMEN, L. V., Kessler, F. H. P., & Schuch, J. B. (2024) · Journal of Dual Diagnosis · doi:10.1080/15504263.2024.2370411 · Cited by 4
Butelman, E. R., Huang, Y., King, S. G., Gaudreault, P., Ceceli, A. O., Kronberg, G., Cathomas, F., Roussos, P., Russo, S. J., Garland, E. L., et al. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100480 · Cited by 2
“Insuf fi cient knowledge about potential biomarkers of treatment outcomes (inclusive of recovery) of people receiving MOUD severely limits the development of personalized approaches and clinical strati fi cation (5,6).”
Moradi, M., Ekhtiari, H., Kuplicki, R., McKinney, B. A., Stewart, J. L., Victor, T. A., & Paulus, M. P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108211 · Cited by 2
“, 2012) and may be involved in maintaining the cycle of addictive behaviors (Volkow et al., 2015).”
BackgroundSilva, J. P. E. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2019.tde-10122019-112107 · Cited by 3
Degoulet, M., Tiran‐Cappello, A., Baunez, C., & Pelloux, Y. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/451203 · Cited by 2
Yu, J., Chen, F., Xu, Y., Shi, K., Zhang, Z., Peng, Q., Xie, Z., Lu, J. N., Wu, H., Ma, Y., et al. (2021) · medRxiv · doi:10.1101/2021.04.19.21255653 · Cited by 3
“Huang C, Fisher KP, Hammer SS, Navitskaya S, Blanchard GJ, Busik JV (2018) Plasma 633 Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the 634 Classical Complement Pathway. Diabetes 67: 1639-1649 635 Jia L, Ye J, L VH, Wang W, Zhou C, Zhang X, Xu J, Wang L, Jia J (2007) Genetic 636 ass…”
BackgroundInfluentialHoughton, D. C., & Spratt, H. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01969-1 · Cited by 2
Predicting Genetic Risk for Impulsivity and Substance Use in AdolescencePreprint
Wade, N. E., Ahern, J., Szpak, V., Wallace, A. L., Sullivan, R. M., Fan, C. C., & Loughnan, R. J. (2025) · medRxiv · doi:10.1101/2025.04.07.25325258 · Cited by 2
“Identification of biomarker predictors of SUD is then imperative for the development of early intervention efforts (Volkow et al., 2015).”
FONG, T. W. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb05 · Cited by 1
Hair Cortisol Concentrations in the Prediction of Early Substance Use Engagement in Youth
Georgiades, A., Godwin, J. W., Andrade, F. C., Copeland, W., Davisson, E. K., Kuhn, C. M., Burnell, K., & Hoyle, R. H. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2423366 · Cited by 1
“…that reflect stress exposure in the association to substance use behaviors, as biomarkers provide an alternative to self-reports and offer further understanding into the neurobiological and behavioral processes involved (Bough & Pollock, 2018; Milivojevic & Sinha, 2018; Volkow et al., 2015).”
Garrido-Matilla, L., Hormigos, R. M., Monago‐Maraña, O., Marcos, A., Ambrosio, E., & Crevillén, A. G. (2025) · Chemosensors · doi:10.3390/chemosensors13030097 · Cited by 1
Nwaneshiudu, C. A., Girdhar, K., Kleopoulos, S. P., Shao, Z., Fullard, J. F., Butelman, E. R., Parvaz, M. A., Goldstein, R. Z., Alia‐Klein, N., & Roussos, P. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70409 · Cited by 1
“Our study demonstrates the prognostic potential of analyzing genome-wide gene expression data from whole blood as a biomarker in longitudinal studies, which remains an important methodological target in SUD and other psychiatric disorders (Budde et al. 2019; Volkow et al. 2015).”
Biomarkers as a Different Approach in Prevention and Treatment of Drug Addiction (Preliminary Study)
Gonidi, M., Tselenti, A., & Plerou, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32633-3_20 · Cited by 1
Repetitive Transcranial Magnetic Stimulation in Addiction
Martinotti, G., Pettorruso, M., Montemitro, C., Ekhtiari, H., Hanlon, C. A., Spagnolo, P. A., Stein, E. A., & Giannantonio, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-43356-7_11 · Cited by 1
Pérez, E. J. P. (2022) · Revista Española de Drogodependencias · doi:10.54108/10007 · Cited by 1
Czoty, P. W., Tryhus, A. M., Sai, K. K. S., Nader, S. H., & Epperly, P. M. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148323 · Cited by 1
Ramírez, M. Ú. P. (2018) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/113164 · Cited by 1
“24 neurocognitive biomarkers that unveil the biological underpinnings of alcohol dependence [2].”
BackgroundGoldberg, A. E. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220421ag · Cited by 2
Differential D 1 and D 2 receptor internalization and recycling induced by amphetamine in vivoPreprint
Hansen, H. D., Schain, M., Deng, H. P., Mandeville, J. B., Rosen, B. R., & Sander, C. Y. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.493955 · Cited by 1
Lima, D. R. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-30012018-113658
Roy, T. (2020) · DigitalCommons (California Polytechnic State University)
Lesmes, S. P. G. (2020) · Gredos (University of Salamanca) · doi:10.14201/gredos.145336
Minority stress, emotion regulation, and substance misuse in sexual minoritiesPreprint
Rogers, A. H., van Dyk, I. S., Haines, N., Hahn, H. A., Aldao, A., & Ahn, W. (2017) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/cxv5z · Cited by 1
(2022) · Revista Española de Drogodependencias · doi:10.54108/10008
D’Ottavio, G. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.002
Paniagua-Ávila, A., Kanguya, T., Mwamba, C., Hahn, J. A., Latkin, C. A., Chander, G., Martins, S. S., Munthali, S., McDonell, M. G., Sharma, A., et al. (2025) · medRxiv · doi:10.1101/2025.08.07.25333191
“…self-report may help to address common issues of self-reported alcohol screening approaches such as social desirability and recall bias, while allowing healthcare providers to establish rapport, facilitating the subsequent phases of the SBIRT program, including counseling and referral [30, 31] .”
Development of New Diagnostic Techniques: Machine Learning
Sun, D., He, X., & Huang, L. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-2411-2_9
Johnson, I. G., & Suzuki, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-57159-6_45-1
Petrie, J. A., Trikha, A., Lundberg, H. L., Bills, K. B., Manwaring, P. K., Obray, J. D., Adams, D. N., Brown, B. L., Fleming, D. E., & Steffensen, S. C. (2025) · Biomedicines · doi:10.3390/biomedicines13123002
From Pathology to Transformation: A Technophilosophy of Addiction
Mylonas, N. (2023) · Edge Hill University Research Information Repository (Edge Hill University)
Paltov, Y. V., Chelpanova, I. V., Pankevych, L. V., & Goleiko, M. V. (2025) · Morphologia · doi:10.26641/1997-9665.2025.3.202-210
Misnan, E., Rashid, R. B. A., Maw, S. S., & Shah, A. M. (2025) · International Journal of Innovation and Industrial Revolution · doi:10.35631/ijirev.723028
Larsson, E., & Åhlman, I. (2025) · Digitala vetenskapliga arkivet (Diva) (Karlstad University)
Broc, G., Borgne, M. L., Gauduchon, A., & Chauchard, É. (2026) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265261438172
Insalaco, W., Clapham, C., Gelino, B. W., Mayo, J. L., Billings, B., Ellis, J. D., Hobelmann, J. G., Huhn, A. S., Zipunnikov, V., & Rabinowitz, J. A. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1755153
Ledouble, C., Maurage, P., Macq, B. M. M., & de Timary, P. (2026) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.25-00439
Song, J., Kim, S. H., Lee, Y.-J., Hobensack, M., Song, H. (., & Landau, A. Y. (2026) · Digital Health · doi:10.1177/20552076261483333
“5,6 Despite being chronic conditions driven by these neurobiological changes, SUDs are frequently construed as personal choices or moral failings, which increases vulnerability to stigmatization in healthcare settings.”
Metadata
- Authors
- Volkow, N. D., Koob, G., & Baler, R.
- Affiliations
- National Institutes of Health (US)
- National Institute on Drug Abuse and ‡National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892, United States
- Corresponding author
- Volkow, Nora D
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-03-18
- Volume
- 6
- Issue
- 4
- Pages
- 522-525
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2057763983
- Cited by
- 141
- References
- 41
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 17 · 2023: 8 · 2022: 18 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 15 · 2017: 10 · 2016: 13 · 2015: 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- substance use disorders, addiction, biomarkers, chronic drug exposure, disease trajectories, treatment response prediction, epigenetics, epitranscriptomics, neuroimaging, EEG, neurochemistry
- MeSH terms
- Animals, Humans, Biomarkers, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.